<DOC>
	<DOCNO>NCT01842074</DOCNO>
	<brief_summary>The investigator plan study role bortezomib desensitize patient await live kidney donation titer Donor Specific anti human leucocyte antigen ( HLA ) Antibody ( DSA ) 1000 3000 MFI pilot study 10 patient recruit 4 hospital FRANCE .</brief_summary>
	<brief_title>Desensitization With Bortezomib Before Living Kidney Donation</brief_title>
	<detailed_description>The investigator plan study role bortezomib desensitize patient await live kidney donation titer Donor Specific anti HLA Antibody ( DSA ) 1000 3000 MFI multicentre pilot study 10 patient . The effect bortezomib observe 6 month bortezomib treatment prior transplantation 12 month transplantation perform . The living kidney donation perform DSA level drop 1000 MFI mean efficacy desensitization .</detailed_description>
	<mesh_term>Bortezomib</mesh_term>
	<criteria>Patient 18 70 year old await live kidney donation least one DSA titer 1000 MFI 3000 MFI positive cell dependent cytotoxicity CM , DSA level 3000 MFI every condition contre indication bortezomib treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>bortezomib</keyword>
	<keyword>desensitization</keyword>
	<keyword>live kidney transplantation</keyword>
</DOC>